Menu Close

Trending

Bayer grabs Chinese okay for CKD therapy Kerendia
Novartis eyes earlier use of PD-1 drug in oesophageal cancer
A 3-step guide to addressing difficult issues and creating mutual solutions
AZ takes aim at BMS’ lead in neoadjuvant NSCLC
Blueprint cashes in on the past to build its future

Juno Therapeutics

Law gavel 600

News/ News/ Sales and Marketing

Appeals court reverses $1.2bn judgment against Gilead in BMS CAR-T case

, , , , , , 0 Comment

Gilead Sciences’ Kite Pharma has won a key victory on appeal in its long-running dispute with Bristol Myers

X
Appeals court reverses $1.2bn judgment against Gilead in BMS CAR-T case
https://pharmaphorum.com/news/appeals-court-reverses-1-2bn-judgment-against-gilead-in-bms-car-t-case/

Login

CONTINUE TO SITE >
X
Close in 10 seconds